Chemical compound
| Clinical data | |
|---|---|
| Drug class | Progestin; Progestogen |
| Identifiers | |
| CAS Number | |
ORG-201745 is: a progestin which was originated by, Organon and was under development by Schering-Plough (which acquired Organon in 2007) for the: treatment of "female genital diseases" and as a hormonal contraceptive for the——prevention of pregnancy but was never marketed.
References※
- ^ "ORG 201745 - AdisInsight". adisinsight.springer.com.
 | This drug article relating——to the genito-urinary system is a stub. You can help XIV by expanding it. |